Dr. Lal Path Labs Share Price

NSE: LALPATHLAB
|
Healthcare Services

₹ 1,938.00

+₹27.40 (1.43%)
1D
Last updated 14 Oct, 2026, 15:55 IST

Dr. Lal Path Labs Share Price Today

As of 14 Oct 2026, Dr. Lal Path Labs share price is ₹1,938.00. The stock opened at ₹1,910.60, compared to its previous close of ₹1,910.60. During today's trading session, Dr. Lal Path Labs share price moved in the range of ₹1,887.10 to ₹1,942.00, with an average price of ₹1,914.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,272.60 and a high of ₹2,038.60. On the performance front, Dr. Lal Path Labs share price has increased by 40.46% over the last six months and is up 22.03% on a year-on-year basis.

₹1,887.10
1.43% up today
₹1,942.00
1D LOW
1D HIGH

Dr. Lal Path Labs Returns Calculator

Volume
2,23,891
Average traded price
₹1,913.47
Last traded time
03:55:05 14 Oct
Last traded quantity
2
Circuit
L
H
₹1,528.50
₹2,292.70
52-week
L
H
₹1,272.60
₹2,038.60
Mkt Cap Cr
32,084.30
P/E
58.73
P/B
12.79
ROA
17.36%
ROE
20.13%
ROCE
25.56%
Quick Ratio
3.38
EV/EBITDA
35.44
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Dr Lal Pathlabs outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Dr Lal Pathlabs appears to be fairly valued compared to its peers
Step 5 of 5
Earnings
Excellent
Dr Lal Pathlabs revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Apollo Hospitals1,12,225.3652.1211.949.79%20.48%17.27%0.9828.14
MANIPAL HEALTH ENTERPRI L87,860.6296.945.354.07%10.59%9.51%1.1735.11
Max Healthcare84,580.6657.687.828.46%13.42%12.97%0.8435.73
Aster DM Healthcare59,426.27165.6314.284.47%8.48%10.1%1.966.42
Fortis Healthcare57,074.8453.315.776.7%10.53%12.56%0.827.65
Global Health35,176.8962.378.79.35%14.05%15.26%2.5433.32
Narayana Hrudayalaya34,465.4542.27.596.55%17.76%11.42%2.0721.3
KRISHNA INST OF MED SCI L29,767.96153.087.942.51%10.74%7.99%0.6839.22
Poly Medicure16,207.7051.85.227.99%10.37%12.71%2.6229.56
MOLBIO DIAGNOSTICS LTD16,953.53117.2212.79.42%15.36%19.08%1.680.0

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Dr. Lal Path Labs

ISIN
INE600L01024
Sector Market Cap
₹ 32,084.30 Cr

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.

Dr. Lal Path Labs Financial Highlights

  • Revenue: Dr. Lal Path Labs reported revenue of ₹2,864.20 crore in FY26 vs ₹2,554.80 crore in FY25. It showed an increase of 12.11% on a yearly basis.
  • Operating Profit: Dr. Lal Path Labs reported an operating profit of ₹669.10 crore in FY26 vs ₹624.70 crore in FY25. It showed an increase of 7.11% on a year-on-year basis.
  • Net Profit: Dr. Lal Path Labs reported a net profit of ₹509.80 crore in FY26 vs ₹492.20 crore in FY25. It showed an increase of 3.58% on a yearly basis.

Dr. Lal Path Labs Quarterly Result Highlights

  • Dr. Lal Path Labs reported revenue of ₹829.60 crore in Jun 2026, compared with ₹726.70 crore in Mar 2026, representing an increase of 14.16% on a quarter-on-quarter (QoQ) basis.
  • Dr. Lal Path Labs reported an operating profit of ₹228.70 crore in Jun 2026, compared with ₹160.10 crore in Mar 2026, representing an increase of 42.85% on a quarter-on-quarter (QoQ) basis.
  • Dr. Lal Path Labs reported a profit of ₹170.50 crore in Jun 2026, compared with ₹132.20 crore in Mar 2026, reflecting an increase of 28.97% on a QoQ basis.
  • The earnings per share (EPS) of Dr. Lal Path Labs stood at ₹30.24 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
53.19%
FII
17.36%
Other DII
2.80%
Retail and other
7.86%
Mutual funds
18.79%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202521.86%
Dec 202520.29%
Mar 202617.18%
Jun 202617.36%
1 day
+1.43%
1 week
-0.37%
1 month
+1.52%
1 year
+22.03%
3 years
+52.16%
5 years
+5.23%
Day
Open / Close
Change %
13 Oct 26
₹1,969.70 / ₹1,910.60
-3.00%
12 Oct 26
₹1,933.00 / ₹1,969.70
+1.87%
09 Oct 26
₹1,898.90 / ₹1,933.60
+1.83%
08 Oct 26
₹1,945.10 / ₹1,898.90
-2.38%
Show more

Dr. Lal Path Labs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,762.91₹2,461.40₹2,226.64₹2,016.88
Other Income₹101.27₹93.43₹69.17₹41.72
Total Revenue₹2,864.18₹2,554.83₹2,295.81₹2,058.60
Total Expenses₹2,165.00₹1,930.03₹1,790.36₹1,714.77
Profit Before Tax₹669.09₹624.80₹505.45₹343.83
Tax₹159.33₹132.55₹143.16₹102.75
Profit After Tax₹509.75₹492.25₹362.29₹241.08
EPS - Basic₹30.24₹58.48₹43.05₹28.82
EPS - Diluted₹30.20₹58.40₹42.98₹28.74

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹509.75₹492.25₹362.29₹241.08
Income before WC changes₹784.37₹731.66₹631.63₹526.99
Change in Assets-₹37.43-₹17.61-₹12.84₹25.09
Change in Liabilities₹64.05₹18.73₹48.58₹10.38
Change in WC₹26.62₹1.12₹35.74₹35.48
Cash flow from Operations₹635.61₹568.89₹535.33₹456.03
Cash flow from Investing-₹421.86-₹303.16-₹24.27-₹287.31
Cash flow from Financing-₹263.57-₹334.03-₹413.86-₹283.18
Total Cash Flow-₹49.83-₹68.31₹97.20-₹114.46
Cash (Start of the year)₹292.63₹360.93₹263.73₹378.20
Cash (End of the year)₹242.80₹292.63₹360.93₹263.73

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,579.50₹1,353.28₹1,329.27₹1,412.48
Current Assets₹1,566.49₹1,363.51₹1,126.70₹973.09
Total Assets₹3,146.00₹2,716.79₹2,455.96₹2,385.56
Current Liabilities₹450.62₹402.35₹465.19₹469.75
Net Current Asset₹1,115.88₹961.16₹661.51₹503.33
Non-Current Liabilities₹154.10₹107.96₹105.41₹216.26
Equity Capital₹2,541.28₹2,206.48₹1,885.36₹1,699.55
Total Equity & Liabilities₹3,146.00₹2,716.79₹2,455.96₹2,385.56

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,647.57₹2,351.62₹2,125.06₹1,769.03
Other Income₹112.74₹111.52₹66.30₹46.60
Total Revenue₹2,760.31₹2,463.14₹2,191.37₹1,815.63
Total Expenses₹2,069.97₹1,841.86₹1,708.84₹1,424.80
Profit Before Tax₹660.25₹621.28₹482.53₹390.83
Tax₹152.04₹124.02₹135.80₹98.47
Profit After Tax₹508.21₹497.27₹346.73₹292.36
EPS - Basic₹30.45₹29.85₹41.72₹35.28
EPS - Diluted₹30.40₹29.81₹41.66₹35.17

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹508.21₹497.27₹346.73₹292.36
Income before WC changes₹755.46₹700.92₹602.75₹487.14
Change in Assets-₹44.63-₹24.29-₹18.35₹19.61
Change in Liabilities₹61.66₹18.00₹48.02₹19.91
Change in WC₹17.03-₹6.29₹29.67₹39.52
Cash flow from Operations₹605.87₹540.00₹504.60₹427.53
Cash flow from Investing-₹382.09-₹293.00₹1.17-₹288.47
Cash flow from Financing-₹255.95-₹324.75-₹410.53-₹270.05
Total Cash Flow-₹32.17-₹77.75₹95.24-₹130.99
Cash (Start of the year)₹266.60₹344.34₹249.10₹351.31
Cash (End of the year)₹234.43₹266.60₹344.34₹220.32

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,554.56₹1,343.67₹1,312.77₹1,510.00
Current Assets₹1,494.59₹1,277.28₹1,036.39₹810.17
Total Assets₹3,049.15₹2,620.95₹2,349.16₹2,320.17
Current Liabilities₹434.44₹388.44₹450.47₹432.16
Net Current Asset₹1,060.16₹888.85₹585.92₹378.01
Non-Current Liabilities₹141.89₹98.28₹97.97₹198.15
Equity Capital₹2,472.83₹2,134.23₹1,800.72₹1,689.86
Total Equity & Liabilities₹3,049.15₹2,620.95₹2,349.16₹2,320.17
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
1938
3
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 3
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
46.79
Neutral
ATR (14)
70.49
Neutral
STOCH(9,6)
28.04
Neutral
STOCH RSI (14)
11.67
Bullish
ADX(9)
23.5
Bearish
UO(9)
42.16
Neutral
ROC(12)
-2.59
Bearish
WillR(14)
-71.96
Neutral
Period
Simple value
Exponential vaue
5D
1931.58
1936.07
10D
1953.59
1941.53
20D
1938.49
1937.81
50D
1924.35
1897.05
100D
1796.23
1806.9
Volume trend — traded volume by day
14 Oct2L
13 Oct0L
12 Oct1L
9 Oct1L
8 Oct2L
7 Oct2L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Dr. Lal Path Labs
Healthcare Services
Add Stock
Add Another

Dr. Lal Path Labs Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.